Procopio, Giuseppe <br/><br/>
Sunitinib and everolimus in  pancreatic neuroendocrine tumors.  [electronic resource] 

 -  Tumori   
 - 394 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>2038-2529 
<br/><br/><label>Standard No.: </label>10.1177/030089161209800319  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Disease-Free Survival<br/>Double-Blind Method<br/>Everolimus<br/>Humans<br/>Hypertension--chemically induced<br/>Indoles--administration & dosage<br/>Neuroendocrine Tumors--drug therapy<br/>Neutropenia--chemically induced<br/>Pancreatic Neoplasms--drug therapy<br/>Pyrroles--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Sirolimus--administration & dosage<br/>Stomatitis--chemically induced<br/>Sunitinib<br/>Treatment Outcome